Re-Irradiation in Squamous Cell Carcinoma of the Head and Neck

[1] Benson, R. et al., ‘Re-irradiation for head and neck squamous cell carcinoma’, Journal of the Egyptian National Cancer Institute, 2017. 29(1): pp. 1–9. BensonR. ‘Re-irradiation for head and neck squamous cell carcinoma’ Journal of the Egyptian National Cancer Institute 2017 29 1 1 9 Search in Google Scholar

[2] Takiar, V. et al., ‘Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses’, International Journal of Radiation Oncology, Biology, Physics, 2016. 95(4): pp. 1117–31. TakiarV. ‘Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses’ International Journal of Radiation Oncology, Biology, Physics 2016 95 4 1117 31 Search in Google Scholar

[3] NCCN, ‘Head and Neck Cancers’, in NCCN Clinical Practice Guidelines in Oncology. 2022. NCCN ‘Head and Neck Cancers’ in NCCN Clinical Practice Guidelines in Oncology 2022 Search in Google Scholar

[4] Vermorken, J.B. et al., ‘Platinum-based chemotherapy plus cetuximab in head and neck cancer’, N Engl J Med, 2008. 359(11): pp. 1116–27. VermorkenJ.B. ‘Platinum-based chemotherapy plus cetuximab in head and neck cancer’ N Engl J Med 2008 359 11 1116 27 Search in Google Scholar

[5] Ward, M.C. et al., ‘Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use Criteria’, Int J Radiat Oncol Biol Phys, 2022. 113(4): pp. 759–86. WardM.C. ‘Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use Criteria’ Int J Radiat Oncol Biol Phys 2022 113 4 759 86 Search in Google Scholar

[6] Janot, F. et al., ‘Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma’, J Clin Oncol, 2008. 26(34): pp. 5518–23. JanotF. ‘Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma’ J Clin Oncol 2008 26 34 5518 23 Search in Google Scholar

[7] Ward, M.C. et al., ‘Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative’, Int J Radiat Oncol Biol Phys, 2018. 100(3): pp. 586–94. doi:10.1016/j.ijrobp.2017.06.012 WardM.C. ‘Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative’ Int J Radiat Oncol Biol Phys 2018 100 3 586 94 10.1016/j.ijrobp.2017.06.012 Open DOISearch in Google Scholar

[8] Caudell, J.J. et al., ‘Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis’, Int J Radiat Oncol Biol Phys, 2018. 100(3): pp. 606–617. doi:10.1016/j.ijrobp.2017.11.036 CaudellJ.J. ‘Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis’ Int J Radiat Oncol Biol Phys 2018 100 3 606 617 10.1016/j.ijrobp.2017.11.036 Open DOISearch in Google Scholar

[9] Bots, W.T.C. et al., ‘Reirradiation of head and neck cancer: Long-term disease control and toxicity’, Head & Neck, 2017. 39(6): pp. 1122–1130. doi:10.1002/hed.24733 BotsW.T.C. ‘Reirradiation of head and neck cancer: Long-term disease control and toxicity’ Head & Neck 2017 39 6 1122 1130 10.1002/hed.24733 Open DOISearch in Google Scholar

[10] Nieder, C. & J. Langendijk, Re-Irradiation: New Frontiers (Medical Radiology). 2nd ed. 2017: Springer. NiederC. LangendijkJ. Re-Irradiation: New Frontiers (Medical Radiology) 2nd ed. 2017 Springer Search in Google Scholar

[11] Spencer, S.A. et al., ‘Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck’, Head & Neck, 2008. 30(3): pp. 281–88. SpencerS.A. ‘Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck’ Head & Neck 2008 30 3 281 88 Search in Google Scholar

[12] Langer, C.J. et al., ‘Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911’, J Clin Oncol, 2007. 25(30): pp. 4800–05. LangerC.J. ‘Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911’ J Clin Oncol 2007 25 30 4800 05 Search in Google Scholar

[13] Salama, J.K. et al., ‘Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma’, Int J Radiat Oncol Biol Phys, 2006. 64(2): pp. 382–91. SalamaJ.K. ‘Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma’ Int J Radiat Oncol Biol Phys 2006 64 2 382 91 Search in Google Scholar

[14] Lee, N. et al., ‘Salvage re-irradiation for recurrent head and neck cancer’, Int J Radiat Oncol Biol Phys, 2007. 68(3): pp. 731–40. LeeN. ‘Salvage re-irradiation for recurrent head and neck cancer’ Int J Radiat Oncol Biol Phys 2007 68 3 731 40 Search in Google Scholar

[15] De Crevoisier, R. et al., ‘Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients’, J Clin Oncol, 1998. 16(11): pp. 3556–62. De CrevoisierR. ‘Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients’ J Clin Oncol 1998 16 11 3556 62 Search in Google Scholar

[16] Bonner, J.A. et al., ‘Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck’, N Engl J Med, 2006. 354(6): pp. 567–78. BonnerJ.A. ‘Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck’ N Engl J Med 2006 354 6 567 78 Search in Google Scholar

[17] Sulman, E.P. et al., ‘IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes’, Int J Radiat Oncol Biol Phys, 2009. 73(2): pp. 399–409. SulmanE.P. ‘IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes’ Int J Radiat Oncol Biol Phys 2009 73 2 399 409 Search in Google Scholar

[18] Mortensen, H.R. et al., ‘Aspiration pneumonia in patients treated with radiotherapy for head and neck cancer’, Acta Oncol., 2013. 52(2): pp. 270–76. doi:10.3109/0284186X.2012.742205 MortensenH.R. ‘Aspiration pneumonia in patients treated with radiotherapy for head and neck cancer’ Acta Oncol 2013 52 2 270 76 10.3109/0284186X.2012.742205 Open DOISearch in Google Scholar

[19] Anschuetz, L. et al., ‘Long-term functional outcome after laryngeal cancer treatment’, Radiation Oncology, 2019. 14(1): p. 101. AnschuetzL. ‘Long-term functional outcome after laryngeal cancer treatment’ Radiation Oncology 2019 14 1 101 Search in Google Scholar

[20] Kamran, S. & A. Viswanathan, ‘Risk and Prevention of Radiation-Induced Cancers’, in: Demos Medical, Radiation Therapy Treatment Effects. 2017: Springer. KamranS. ViswanathanA. ‘Risk and Prevention of Radiation-Induced Cancers’ in: Demos Medical, Radiation Therapy Treatment Effects 2017 Springer Search in Google Scholar

[21] Kumar, S., ‘Second malignant neoplasms following radiotherapy’, International journal of environmental research and public health, 2012. 9(12): pp. 4744–59. KumarS. ‘Second malignant neoplasms following radiotherapy’ International journal of environmental research and public health 2012 9 12 4744 59 Search in Google Scholar